NCT04629664View on ClinicalTrials.gov

FX-322 in Adults With Severe Sensorineural Hearing Loss

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 2, 2020

Primary Completion Date

May 26, 2021

Study Completion Date

September 20, 2021

Conditions
Hearing Loss, SensorineuralNoise Induced Hearing LossSudden Hearing Loss
Interventions
DRUG

FX-322

Active Comparator

OTHER

Placebo

Placebo

Trial Locations (7)

00000

Clinical Trial Site, Novi

Clinical Trial Site, Omaha

Clinical Trial Site, Amherst

Clinical Trial Site, Orangeburg

Clinical Trial Site - San Antonio #1, San Antonio

Clinical Trial Site - San Antonio #2, San Antonio

Clinical Trial Site, Norfolk

Sponsors
All Listed Sponsors
lead

Frequency Therapeutics

INDUSTRY